Ovarian cancer: open trials in Denmark

22 open trials have a site in Denmark. Registry data; only the trial team decides who can take part.

NCT07546500
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Trial Treatment · Phase 3 · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Aalborg · Copenhagen · Roskilde
Registry updated 2026-11-09
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Aarhus University Hospital | Oncology Department - Clinical Research Unit, Aarhus N · Rigshospitalet Copenhagen University Hospital | Oncology Department, Copenhagen · Odense University Hospital | Svendborg Sygehus - Oncology Department, Odense
Registry updated 2026-11-04
NCT07213804
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Rigshospitalet, Copenhagen · Vejle Sygehus, Vejle
Registry updated 2026-11-04
NCT06072781
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Trial Treatment · Phase 3 · Verastem, Inc.
Aalborg University Hospital, Aalborg
Registry updated 2026-11-02
NCT06819007
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Trial Treatment · Phase 3 · Daiichi Sankyo
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Region Sjaelland, Roskilde
Registry updated 2026-10-28
NCT06824467
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Aalborg University Hospital, Aalborg · Rigshospitalet, Copenhagen Oe · Region Hovedstaden, Herlev · Lillebaelt Hospital, Vejle
Registry updated 2026-10-13
NCT07059845
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Trial Treatment · Phase 2 · AbbVie
Aalborg University Hospital, Aalborg · Region Hovedstaden, Herlev · Odense University Hospital, Odense C
Registry updated 2026-10-13
NCT07278336
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Trial Treatment · Phase 1 · AbbVie
Rigshospitalet, Copenhagen Oe
Registry updated 2026-10-13
NCT07318558
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Region Hovedstaden, Herlev · Odense University Hospital, Odense C
Registry updated 2026-10-13
NCT06276491
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Trial Treatment · Phase 1 · Xencor, Inc.
Herlev & Gentofte Hospital, Herlev
Registry updated 2026-10-09
NCT06997029
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Trial Treatment · Phase 1 · Bristol-Myers Squibb
Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-10-06
NCT07225270
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Trial Treatment · Phase 3 · Genmab
Aalborg University Hospital, Aalborg · Rigshospitalet, Copenhagen Oe · Region Sjaelland, Roskilde
Registry updated 2026-10-06
NCT04752826
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Trial Treatment · Phase 1/2 · BioInvent International AB
Rigshospitalet, Copenhagen · Herlev Hospital, Herlev
Registry updated 2026-09-18
NCT07733505
Normethermic Intraperitoneal Chemotherapy - a Novel Concept for Local Treatment of the Elderly and Fragile Women With Advanced Ovarian Cancer?
Trial Treatment · Phase 1 · Odense University Hospital
Odense University Hospital, Odense C
Registry updated 2026-07-29
NCT07218809
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Trial Treatment · Phase 3 · AstraZeneca
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Odense University Hospital, Odense C · Sygehus Lillebaelt - Vejle Sygehus, Vejle
Registry updated 2026-07-21
NCT04641247
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Trial Treatment · Phase 2 · GlaxoSmithKline
Odense C
Registry updated 2026-06-24
NCT05574673
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
Research · Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Rigshospitalet, København Ø
Registry updated 2026-02-27
NCT06234423
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Trial Treatment · Phase 1 · OnCusp Therapeutics, Inc.
Rigshospitalet, Copenhagen Oe
Registry updated 2026-01-14
2023-503398-39-00
IMPROCAS - Improved Prediction of Ovarian Cancer Surgery
Trial Treatment · Phase 2 · Aarhus University
Aarhus Universitet, Aarhus N
Registry updated 2025-05-30
NCT05763511
Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Research · University of Aarhus
Department of Gynaecology and Obstetrics, Aarhus University Hospital, Aarhus
Registry updated 2024-05-09
NCT05842629
Improved Diagnosis of Ovarian Cancer
Research · University of Aarhus
Department of Gynaecology and Obstetrics, Aarhus University Hospital, Aarhus
Registry updated 2024-05-09
NCT05810701
FRAGINOC Study: Screening and Geriatric Assessment and Intervention in Older Patients With Epithelial Ovarian Cancer
Trial Treatment · Odense University Hospital
Copenhagen University Hospital, Rigshospitalet, Copenhagen · Herlev and Gentofte Hospital, Herlev · Odense University Hospital, Odense · Zealand University Hospital, Roskilde · Vejle Hospital, Vejle
Registry updated 2023-04-12

All Ovarian cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error